- Report
- January 2026
- 186 Pages
Global
From €3158EUR$3,545USD£2,732GBP
€3508EUR$3,939USD£3,036GBP
- Report
- February 2026
- 250 Pages
Global
From €3999EUR$4,490USD£3,460GBP
- Report
- February 2026
- 250 Pages
Global
From €3999EUR$4,490USD£3,460GBP
- Report
- February 2026
- 250 Pages
Global
From €3999EUR$4,490USD£3,460GBP
- Report
- February 2026
- 250 Pages
Global
From €3999EUR$4,490USD£3,460GBP
- Report
- February 2026
- 250 Pages
Global
From €3999EUR$4,490USD£3,460GBP
- Report
- May 2026
- 389 Pages
Global
From €5210EUR$5,850USD£4,509GBP
- Report
- June 2025
- 200 Pages
Global
From €2484EUR$2,789USD£2,150GBP
- Report
- August 2025
- 116 Pages
Global
From €3562EUR$3,999USD£3,082GBP
- Report
- August 2025
- 143 Pages
Global
From €3562EUR$3,999USD£3,082GBP
- Report
- July 2025
- 210 Pages
Global
From €4449EUR$4,995USD£3,850GBP
- Report
- April 2026
- 140 Pages
United Kingdom
From €5299EUR$5,950USD£4,586GBP
- Report
- March 2024
- 200 Pages
Global
From €3696EUR$4,150USD£3,198GBP
- Report
- April 2024
- 173 Pages
Global
From €4008EUR$4,500USD£3,468GBP
- Report
- May 2025
- 185 Pages
Global
From €4008EUR$4,500USD£3,468GBP
- Report
- August 2023
- 74 Pages
Canada
From €3117EUR$3,500USD£2,697GBP
- Report
- March 2026
- 150 Pages
Canada
From €4320EUR$4,850USD£3,738GBP
- Report
- March 2026
- 150 Pages
China
From €4320EUR$4,850USD£3,738GBP
- Report
- March 2026
- 150 Pages
Germany
From €4320EUR$4,850USD£3,738GBP
- Report
- March 2026
- 150 Pages
India
From €4320EUR$4,850USD£3,738GBP

The Cholesterol Drug market is a subset of the Cardiovascular Drugs market, which includes drugs used to treat conditions related to the heart and circulatory system. Cholesterol Drugs are used to reduce levels of low-density lipoprotein (LDL) cholesterol, which is a major risk factor for cardiovascular disease. These drugs are typically prescribed to patients with high cholesterol levels, or to those at risk of developing cardiovascular disease. Common types of Cholesterol Drugs include statins, bile acid sequestrants, fibrates, and cholesterol absorption inhibitors.
Some companies in the Cholesterol Drug market include Pfizer, Merck, AstraZeneca, Sanofi, and Novartis. Show Less Read more